论文部分内容阅读
本文比较肝细胞癌的经导管动脉栓塞(TAE)与一次射击化疗的疗效和预后。方法选用90例不能切除的肝细胞癌,其中40例(男31,女9)用 TAE 治疗(TAE 组),50例(男42,女8)用一次射击化疗(化疗组)。疗效评价用血清甲胎蛋白(AFP)、肝血管造影、CT 和超声波描记(US)。治疗后主要以血管造影佐以 CT 和 US,定出瘤体缩小过半为部分有效,缩小25～50%为低效,
This article compares the efficacy and prognosis of transcatheter arterial embolization (TAE) versus one shot chemotherapy for hepatocellular carcinoma. METHODS: Ninety cases of unresectable hepatocellular carcinoma were selected. Among them, 40 cases (male 31, female 9) were treated with TAE (TAE group) and 50 cases (male 42, female 8) were treated with one shot chemotherapy (chemotherapy group). Efficacy was evaluated using serum alpha-fetoprotein (AFP), hepatic angiography, CT, and ultrasonography (US). After the treatment, the angiography was mainly combined with CT and US. It was determined that the reduction of the tumor mass was more than half effective. The reduction of 25 to 50% was ineffective.